Preoperative Vitamin B12 and Folic Acid on POCD in Elderly Non-cardiac Surgical Patients (B12-POCD)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03485404 |
|
Recruitment Status :
Terminated
(Due to slow recruiment. Only 40 patients were recruited in four years.)
First Posted : April 2, 2018
Last Update Posted : August 4, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Post Operative Cognitive Dysfunction | Drug: methylcobalamin Drug: Folic Acid Other: Placebo for methylcobalamin Other: Placebo for folic acid Procedure: non-cardiac surgery Behavioral: NPB test | Not Applicable |
Vitamin B12 has long been suggested to have neural nutrient effect and widely used in clinical settings for patients with peripheral nerve injury as well as complementary medicine for patients with CNS disorders, including cognitive dysfunction. Evidences showed that, although no significant improvement in cognitive function was observed in healthy elderly after vitamin B12 supplementation, some studies suggested that patients with pre-existing CNS disorder may benefit from Vitamin B12. Post operational cognitive dysfunction (POCD) is severe, and long-lasting complication that affects as high as 53% of patients in high risk surgeries. Age is an independent risk factor for POCD. Researches have shown that serum vitamin B12 level decrease with age, and methylcobalamin (active form of Vitamin B12) content in the frontal cortex of aged patients are lower than that of younger patients. However, there are no report on effect of preemptive supplementation of vitamin B12 on POCD incidence. Therefore, the current research is aimed to explore the preoperative methylcobalamin supplementation (500 mg, 3/day for 7 days before surgery) on incidence of POCD. Folic acid supplementation is a common companion for vitamin B12 treatment in clinical settings because they are in the same methionine cycle, increase of one may result in deficiency of another. So we added 5 mg, 1/day of folic acid with methylcobalamin in the treatment group.
This study will recruit patients more than 65 years old eligible for non-cardiac surgery. Patients who participate will take either vitamin B12 and folic acid supplementation or placebo for 7 days before surgery. Neuropsychological test battery (NPB) will be tested before intervention and at discharge for determination of Post operative cognitive dysfunction (POCD). Another group of non-surgical elderly participants will also be tested for NPB to account for learning effect in POCD diagnosis. The hypothesis is that preoperative vitamin B12 supplementation will reduce the incidence of POCD in elderly patients undergoing non-cardiac surgery.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 40 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Double (Participant, Care Provider) |
| Masking Description: | Central randomization. Groups are marked as A and B with no participants, care provider, investigator and outcome assessors know which group is the drug and which is the placebo. Placebo are made as tablets that mimics the color, shape and size of the drugs. |
| Primary Purpose: | Prevention |
| Official Title: | Effect of Preoperative Vitamin B12 on Post Operative Cognitive Dysfunction in Elderly Patients Undergoing Non-cardiac Surgery: A Multi-Center, Prospective, Randomized, Double-blinded, Controlled Clinical Trial |
| Actual Study Start Date : | January 10, 2019 |
| Actual Primary Completion Date : | July 29, 2021 |
| Actual Study Completion Date : | July 29, 2021 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: VB12+FA
Patients will receive oral supplementation of 0.5mg methylcobalamin, 3/day and 5 mg folic acid, 1/day for 7 days before non-cardiac surgery.
|
Drug: methylcobalamin
methylcobalamin tablets, 0.5mg/tablet, 3 tablets/day.
Other Names:
Drug: Folic Acid folic acid tablets, 5mg/tablet, 1 tablet/day
Other Name: vitamin B9 Procedure: non-cardiac surgery patients elective for non-cardiac surgery will undergo scheduled surgery after 7 days of intervention Behavioral: NPB test participants will accept Mini-Mental State Examination (MMSE), Patient Health Questionnaire (PHQ-9), ADL, and NPB test before intervention, and NPB by discharge or similar time intermittent after the first assessment for non-surgical controls. Also ADL will be tested again through telephone interview at 3 months after discharge.
Other Names:
|
|
Placebo Comparator: Placebo
Patients with receive oral tablets of placebo for folic acid 1/d and placebo for methylcobalamin 3/d, which look exactly like the interventional drugs as oral supplementation for 7 days before non-cardiac surgery.
|
Other: Placebo for methylcobalamin
orange tablets that looks exactly like methylcobalamin Other: Placebo for folic acid yellow tablets that looks exactly like folic acid Procedure: non-cardiac surgery patients elective for non-cardiac surgery will undergo scheduled surgery after 7 days of intervention Behavioral: NPB test participants will accept Mini-Mental State Examination (MMSE), Patient Health Questionnaire (PHQ-9), ADL, and NPB test before intervention, and NPB by discharge or similar time intermittent after the first assessment for non-surgical controls. Also ADL will be tested again through telephone interview at 3 months after discharge.
Other Names:
|
|
Non-surgical controls
Age and sex-matched community elderly people are included for two sessions of NPB test evaluation for calculation of POCD incidence as normal control to in Z value calculation of POCd incidence to rule out learning effect.
|
Behavioral: NPB test
participants will accept Mini-Mental State Examination (MMSE), Patient Health Questionnaire (PHQ-9), ADL, and NPB test before intervention, and NPB by discharge or similar time intermittent after the first assessment for non-surgical controls. Also ADL will be tested again through telephone interview at 3 months after discharge.
Other Names:
|
- Incidence of POCD at discharge or 7 days after operation [ Time Frame: at discharge or at 7 days after operation if the patient is not discharged by then ]POCD incidence is defined as two or more test of the neuropsychological battery declined as compared to preoperative baseline.
- Activity daily living score [ Time Frame: 3 months after operation ]Telephone interview of activity daily living score （14 items， 1-4 points per item, ranging 14-56 points with 56 being the worst-unable to complete any task of everyday living.）
- Serum level of vitamin B12, folic acid and homocysteine [ Time Frame: Immediately before anesthesia, immediately after surgery and on the morning of postoperative day 1 ]Ten ml of venous blood will be collected from patients to test the differences of serum levels of vitamin B12, folic acid and homocysteine to show the effect of preoperative supplementation and surgery stimulation on these parameters.
- Serum level of cystatin C and myeloid differentiation protein 2 [ Time Frame: Immediately before anesthesia, immediately after surgery and on the morning of postoperative day 1 ]Ten ml of venous blood will be collected from patients to test the differences of serum levels of cystatin C and myeloid differentiation protein 2.
- Length of hospital stay [ Time Frame: Date from hospital admission to hospital discharge. This length is usually around 7-14 days. It may be longer if the patient have one or more complications. The length will be documented at patient discharge, up to 100 weeks. ]to see if our intervention could reduce the total days of patient spent in hospital,
- Incidence of in hospital complications [ Time Frame: From date of hospital admission to date of hospital discharge after surgery. Usually 7-14 days, assessed up to 100 weeks. ]Overall rate of perioperative major complications including hemorrhage, deep vein thrombosis, cardiovascular complications, respiratory complications, acute kidney injury, infection or second operative needed, during patient's hospital stay.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 65 Years and older (Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 1. Age equals or over 65
- 2. Scheduled for spinal or joint replacement surgery under general anesthesia，estimated surgery time over 2h.
- 3. Signed written informed consent obtained
- 4. Non-surgical Controls are age and sex - matched community elderly residents.
Exclusion Criteria:
- 1. Disease of the central nervous system that impairs cognitive function, including all kinds of dementia, and depression
- 2. MMSE score < 24
- 3. Received education for less than 5 years
- 4. Currently taking sedative or antidepressant drugs
- 5. Has taken vitamin B12, folic acid or their derivatives (methycobalamin, cobalamin, tetrahydrofolic acid, etc.) within 6 months.
- 6. Has accepted cardiac or neurological surgery within one year.
- 7. Was admitted for other clinical trials within 3 month
- 8. Patients that regularly taking drugs that affect vitamin B absorption, including colchicine, neomycin, salicylate.
- 9. Has severe visual or auditory problems
- 10. Alcohol or drug dependent (alcohol dependent: drank more than 100 mL of Chinese liqueur with alcohol concentration over 40% everyday for the past 3 months).
- 11. Patients that are already admitted for this study can not be admitted the second time, no matter the cause of surgery
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03485404
| China, Anhui | |
| Anhui Provincial Hospital | |
| Hefei, Anhui, China, 230001 | |
| China, Guangdong | |
| Shenzhen University General Hospital | |
| Shenzhen, Guangdong, China | |
| China, Hebei | |
| The Third Hospital of Hebei Medical University | |
| Shijiazhuang, Hebei, China | |
| China, Henan | |
| Henan Provincial People's Hospital | |
| Zhengzhou, Henan, China | |
| China, Jiangsu | |
| Nanjing Drum Tower Hospital | |
| Nanjing, Jiangsu, China, 210008 | |
| China, Shaanxi | |
| First Affiliated Hospital of Xi'an Jiaotong University | |
| Xi'an, Shaanxi, China, 710032 | |
| Shaanxi Provincial People's Hospital | |
| Xi'an, Shaanxi, China, 710032 | |
| Tangdu Hospital | |
| Xi'an, Shaanxi, China, 710032 | |
| Xijing Hospital | |
| Xi'an, Shaanxi, China, 710032 | |
| China, Shandong | |
| Shandong Provincial Qianfoshan Hospital | |
| Jinan, Shandong, China | |
| China | |
| Shanghai 10th People's Hospital | |
| Shanghai, China, 200072 | |
| Shanghai Changzheng Hospital | |
| Shanghai, China | |
| Shanghai Forth People's Hospital | |
| Shanghai, China | |
| Study Chair: | Lize Xiong, M.D., Ph.D. | Xijing Hospital |
| Responsible Party: | Lize Xiong, Professor, Xijing Hospital |
| ClinicalTrials.gov Identifier: | NCT03485404 |
| Other Study ID Numbers: |
KY20172057-1 |
| First Posted: | April 2, 2018 Key Record Dates |
| Last Update Posted: | August 4, 2021 |
| Last Verified: | July 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
POCD vitamin B12 folic acid |
|
Postoperative Cognitive Complications Cognitive Dysfunction Cognition Disorders Neurocognitive Disorders Mental Disorders Postoperative Complications Pathologic Processes |
Vitamins Folic Acid Vitamin B 12 Vitamin B Complex Micronutrients Physiological Effects of Drugs Hematinics |